Literature DB >> 23438834

Thyroid dysfunction in the elderly.

Kristien Boelaert1.   

Abstract

Thyroid dysfunction is common in the general population, and mild or subclinical forms can be present in more than 10% of individuals aged >80 years. The diagnosis of abnormal thyroid hormone concentrations in people aged >60 years poses a challenge, as the clinical presentation of thyroid dysfunction is usually nonspecific, and ageing is associated with a number of physiological changes that can affect thyroid function test results. Furthermore, the presence of acute or chronic nonthyroidal illnesses and the use of medications that interfere with thyroid function tests are common confounders in the determination of thyroid status in the elderly. Early diagnosis and treatment of overt thyroid dysfunction is crucial in this population in view of the marked effects of abnormal circulating thyroid hormone levels on a number of organ systems, including the heart, the skeleton and the neurological system. The clinical significance of mild thyroid overactivity and underactivity remains uncertain, and the need for treatment of subclinical thyroid dysfunction is much debated. A number of large epidemiological studies have identified associations between mild thyroid dysfunction and short-term as well as long-term adverse outcomes, and a small but increasing number of randomized controlled intervention studies have been reported. Guidelines recommend treatment of thyroid dysfunction on the basis of the degree of abnormal serum TSH concentrations, patient age and associated comorbidities. This Review describes the current evidence on the prevalence, diagnosis, management and long-term consequences of thyroid dysfunction in the elderly.

Entities:  

Mesh:

Year:  2013        PMID: 23438834     DOI: 10.1038/nrendo.2013.30

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  146 in total

1.  Thyroxine turnover in euthyroid man with special reference to changes with age.

Authors:  R I GREGERMAN; G W GAFFNEY; N W SHOCK; S E CROWDER
Journal:  J Clin Invest       Date:  1962-11       Impact factor: 14.808

2.  Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study.

Authors:  Faizel Osman; Jayne A Franklyn; Roger L Holder; Michael C Sheppard; Michael D Gammage
Journal:  J Am Coll Cardiol       Date:  2006-12-13       Impact factor: 24.094

Review 3.  Hypothalamic thyroid hormone feedback in health and disease.

Authors:  Eric Fliers; Anneke Alkemade; Wilmar M Wiersinga; Dick F Swaab
Journal:  Prog Brain Res       Date:  2006       Impact factor: 2.453

Review 4.  Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature.

Authors:  M D Danese; P W Ladenson; C L Meinert; N R Powe
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

5.  Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women.

Authors:  J Faber; I W Jensen; L Petersen; B Nygaard; L Hegedüs; K Siersbaek-Nielsen
Journal:  Clin Endocrinol (Oxf)       Date:  1998-03       Impact factor: 3.478

6.  Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism.

Authors:  Saara Metso; Pia Jaatinen; Heini Huhtala; Anssi Auvinen; Heikki Oksala; Jorma Salmi
Journal:  J Clin Endocrinol Metab       Date:  2007-03-20       Impact factor: 5.958

Review 7.  Thyroid disease and the heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  Circulation       Date:  2007-10-09       Impact factor: 29.690

8.  Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality.

Authors:  Anthony J O'Sullivan; Mridula Lewis; Terrance Diamond
Journal:  Eur J Endocrinol       Date:  2006-04       Impact factor: 6.664

Review 9.  Ageing populations: the challenges ahead.

Authors:  Kaare Christensen; Gabriele Doblhammer; Roland Rau; James W Vaupel
Journal:  Lancet       Date:  2009-10-03       Impact factor: 79.321

10.  Association between serum free thyroxine concentration and atrial fibrillation.

Authors:  M D Gammage; J V Parle; R L Holder; L M Roberts; F D R Hobbs; S Wilson; M C Sheppard; J A Franklyn
Journal:  Arch Intern Med       Date:  2007-05-14
View more
  20 in total

1.  Clinical outcomes of patients with hypothyroidism undergoing percutaneous coronary intervention.

Authors:  Ming Zhang; Jaskanwal D S Sara; Yasushi Matsuzawa; Hossein Gharib; Malcolm R Bell; Rajiv Gulati; Lilach O Lerman; Amir Lerman
Journal:  Eur Heart J       Date:  2016-01-12       Impact factor: 29.983

Review 2.  Liquid and softgel levothyroxine use in clinical practice: state of the art.

Authors:  Camilla Virili; Pierpaolo Trimboli; Francesco Romanelli; Marco Centanni
Journal:  Endocrine       Date:  2016-07-29       Impact factor: 3.633

3.  Reference intervals for thyrotropin in an area of Northern Italy: the Pordenone thyroid study (TRIPP).

Authors:  R Tozzoli; F D'Aurizio; P Metus; A Steffan; C Mazzon; M Bagnasco
Journal:  J Endocrinol Invest       Date:  2018-01-16       Impact factor: 4.256

Review 4.  Extracellular RNA in aging.

Authors:  Douglas F Dluzen; Nicole Noren Hooten; Michele K Evans
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-08-17       Impact factor: 9.957

5.  Gender and Age-Specific Differences in the Association of Thyroid Function and Hyperuricemia in Chinese: A Cross-Sectional Study.

Authors:  Ming Yang; Suyan Cao
Journal:  Int J Endocrinol       Date:  2022-07-05       Impact factor: 2.803

6.  Clinical profile of 80-year-old and older thyroid eye disease patients.

Authors:  Niv Levy; Hana Leiba; Klara Landau; Ofira Zloto; Ruth Huna-Baron
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-26       Impact factor: 3.535

7.  Mechanism of subclinical hypothyroidism accelerating endothelial dysfunction (Review).

Authors:  Ming Lu; Chong-Bo Yang; Ling Gao; Jia-Jun Zhao
Journal:  Exp Ther Med       Date:  2014-10-27       Impact factor: 2.447

8.  Expert consensus on diagnosis and treatment for elderly with thyroid diseases in China (2021).

Authors:  Youshuo Liu; Zhongyan Shan
Journal:  Aging Med (Milton)       Date:  2021-07-02

9.  Levothyroxine dose and fracture risk according to the osteoporosis status in elderly women.

Authors:  Young-Jin Ko; Ji Young Kim; Joongyub Lee; Hong-Ji Song; Ju-Young Kim; Nam-Kyong Choi; Byung-Joo Park
Journal:  J Prev Med Public Health       Date:  2014-01-29

10.  Iodine Status of New Zealand Elderly Residents in Long-Term Residential Care.

Authors:  Jody C Miller; Sue O MacDonell; Andrew R Gray; Malcolm R Reid; David J Barr; Christine D Thomson; Lisa A Houghton
Journal:  Nutrients       Date:  2016-07-23       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.